Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q4 2025 investor letter. A ...

Haemonetics Corporation (NYSE:HAE) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On ...

Currently priced at approximately $80.53 per share, Haemonetics (NYSE: HAE) is trading roughly 7.6% below its 52-week high. Do you believe HAE stock represents a solid long-term investment at its ...

Haemonetics Corporation’s HAE impressive potential of the Plasma franchise is poised to drive growth in the upcoming quarters. The robust uptake of the Hemostasis Management Franchise bodes well for ...

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - specialty stocks, ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value ...